These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B, Bode U, von Schweinitz D. Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356 [Abstract] [Full Text] [Related]
5. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin. Seo T, Ando H, Watanabe Y, Harada T, Ito F, Kaneko K, Horibe K, Sugito T, Ito T. Surgery; 1998 Apr; 123(4):407-14. PubMed ID: 9551066 [Abstract] [Full Text] [Related]
6. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC. J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104 [Abstract] [Full Text] [Related]
8. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G. J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943 [Abstract] [Full Text] [Related]
9. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J. Cancer; 2000 Oct 15; 89(8):1845-53. PubMed ID: 11042582 [Abstract] [Full Text] [Related]
10. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N, (Japanese Study Group for Pediatric Liver Tumor). J Pediatr Surg; 2002 Jun 15; 37(6):851-6. PubMed ID: 12037748 [Abstract] [Full Text] [Related]
11. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H. Eur J Cancer; 1997 Jul 15; 33(8):1243-9. PubMed ID: 9301450 [Abstract] [Full Text] [Related]
12. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A. Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482 [Abstract] [Full Text] [Related]
13. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL). Lancet Oncol; 2013 Aug 15; 14(9):834-42. PubMed ID: 23831416 [Abstract] [Full Text] [Related]
15. Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival. Powers JM, Pacheco MM, Wickiser JE. J Pediatr Hematol Oncol; 2019 Apr 15; 41(3):e171-e173. PubMed ID: 29668545 [Abstract] [Full Text] [Related]
16. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology. Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J. J Clin Oncol; 2000 Nov 15; 18(22):3819-28. PubMed ID: 11078495 [Abstract] [Full Text] [Related]
17. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM. J Clin Oncol; 2017 Oct 20; 35(30):3465-3473. PubMed ID: 28892430 [Abstract] [Full Text] [Related]
18. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin. Sivaprakasam P, Gupta AA, Greenberg ML, Capra M, Nathan PC. J Pediatr Hematol Oncol; 2011 Aug 20; 33(6):e226-30. PubMed ID: 21792028 [Abstract] [Full Text] [Related]
19. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V]. Liu G, Liu B, Li K, Dong K, Xiao X. Zhonghua Er Ke Za Zhi; 2015 Feb 20; 53(2):119-23. PubMed ID: 25876687 [Abstract] [Full Text] [Related]
20. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma. Carceller A, Blanchard H, Champagne J, St-Vil D, Bensoussan AL. J Pediatr Surg; 2001 May 20; 36(5):755-9. PubMed ID: 11329582 [Abstract] [Full Text] [Related] Page: [Next] [New Search]